New hope for treating the toughest cancers
December 20, 2022
The Mays Cancer Center at UT Health San Antonio — South Texas’ only National Cancer Institute-Designated Cancer Center — is putting a decades-old antidepressant drug to new use treating breast cancers that don’t respond to existing therapies. Research …
New hope for treating the toughest cancers
December 20, 2022
The Mays Cancer Center at UT Health San Antonio — South Texas’ only National Cancer Institute-Designated Cancer Center — is putting a decades-old antidepressant drug to new use treating breast cancers that don’t respond to existing therapies. Research …
KSAT 12: Alamo Center staying busy with opioid epidemic
December 19, 2022
Jennifer Sharpe Potter, PhD, MPH, vice president for research and professor of psychiatry and behavioral sciences and executive director, Be Well Texas, was quoted in this news story. Read More
KSAT 12: San Antonio nursing student turned ‘living legend’ wins national award
December 19, 2022
Norma Martinez Rogers, PhD, RN, FAAN, professor emeritus in the School of Nursing, was interviewed for this news story. Read More
Texas Monthly: Texas’s Doctor Shortage is Bilingual
December 16, 2022
Francisco Cigarroa, Director, Transplant Center and former UT Health president and chancellor, was quoted in this story. Read More
Medpage Today: What the SABCS ‘Year in Review’ Session May Bring in 2023
December 16, 2022
Virginia Kaklamani, MD, Medical Oncology, co-director of the San Antonio Breast Cancer Symposium, was quoted in the symposium’s “Year in Review” session. Read More
KENS 5: UT Health Science Center in San Antonio working to develop a vaccine for chlamydia
December 16, 2022
UT Health was mentioned in this news segment. Read More
The Orange Leader: UT Health San Antonio, Ohio company reach license agreement to develop chlamydia vaccine
December 16, 2022
Guangming Zhong, MD, PhD, Microbiology, Immunology & Molecular Genetics, was quoted in this story. Read More
Port Arthur News: UT Health San Antonio, Ohio company reach license agreement to develop chlamydia vaccine
December 16, 2022
Guangming Zhong, MD, PhD, Microbiology, Immunology & Molecular Genetics, was quoted in this story. Read More
El Paso Inc.: UT Health San Antonio, Ohio company reach license agreement to develop chlamydia vaccine
December 16, 2022
Guangming Zhong, MD, PhD, Microbiology, Immunology & Molecular Genetics, was quoted in this story. Read More